Literature DB >> 34261900

Review of the Metabolic Risk Factors for Increased Severity of Coronavirus Disease 2019.

Tzvi Fishkin1, Michael D Goldberg, William H Frishman.   

Abstract

The coronavirus-2019 (COVID-19) pandemic has presented many new challenges to the healthcare community with the sheer number of individuals affected and the range of symptoms at presentation. Early findings have shown that increased age is an independent risk factor for COVID-19 severity. Diabetes and hypertension were also found to be strong independent risk factors for severe COVID-19. It was later discovered that obesity is a strong risk factor for severe disease as well. Possible mechanisms for the increased risk associated with metabolic disease include increased prevalence of acute respiratory syndrome, immune cell dysfunction, and chronic inflammatory states associated with obesity and diabetes. Acknowledging these risk factors has consequences for addressing vaccination strategies as well as healthcare disparities.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 34261900     DOI: 10.1097/CRD.0000000000000408

Source DB:  PubMed          Journal:  Cardiol Rev        ISSN: 1061-5377            Impact factor:   2.644


  3 in total

1.  [Influence of umbilical cord milking versus delayed cord clamping on the early prognosis of preterm infants with a gestational age of <34 weeks: a Meta analysis].

Authors:  Wei-Wei Jiang; Xue-Mei Fan; Jia-Hua Zhang; Zi-Man Fu; Cong-Shan Pu; Chun-Jian Shan
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-05-15

Review 2.  The Renin-Angiotensin System as a Component of Biotrauma in Acute Respiratory Distress Syndrome.

Authors:  Katharina Krenn; Verena Tretter; Felix Kraft; Roman Ullrich
Journal:  Front Physiol       Date:  2022-04-13       Impact factor: 4.755

3.  Comparison of drug prescribing before and during the COVID-19 pandemic: A cross-national European study.

Authors:  Iva Selke Krulichová; Gisbert W Selke; Marion Bennie; Mohammadhossein Hajiebrahimi; Fredrik Nyberg; Jurij Fürst; Kristina Garuolienė; Elisabetta Poluzzi; Juraj Slabý; Corinne Zara Yahni; Mattia Altini; Maria Pia Fantini; Václav Kočí; Stuart McTaggart; Caridad Pontes; Chiara Reno; Simona Rosa; Marta Turu Pedrola; Mitja Udovič; Björn Wettermark
Journal:  Pharmacoepidemiol Drug Saf       Date:  2022-07-18       Impact factor: 2.732

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.